Buprenorphine Transdermal Patch and Dolutegravir 25 mg and 50 mg
Determining the interaction of Buprenorphine Transdermal Patch and Dolutegravir 25 mg and 50 mg and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: buprenorphine
Brand name: Probuphine, Belbuca, Buprenex, Butrans, Sublocade, Subutex
Synonyms: Buprenorphine (implant), Buprenorphine
Generic Name: dolutegravir
Brand name: Tivicay
Synonyms: Dolutegravir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Buprenorphine Transdermal Patch-Dolutegravir and lamivudine
- Buprenorphine Transdermal Patch-Dolutegravir and rilpivirine
- Buprenorphine Transdermal Patch-Dolutegravir Sodium
- Buprenorphine Transdermal Patch-Dolutegravir Sodium And Lamivudine
- Buprenorphine Transdermal Patch-Dolutegravir Sodium and Rilpivirine Hydrochloride
- Buprenorphine Transdermal Patch-Dom-Etoposide
- Dolutegravir 25 mg and 50 mg-Buprenorphine transdermal skin patch
- Dolutegravir 25 mg and 50 mg-Buprenorphine, Buprenorphine Hydrochloride
- Dolutegravir 25 mg and 50 mg-Buprenorphine/naloxone Oromucosal, Sublingual
- Dolutegravir 25 mg and 50 mg-Buproban
- Dolutegravir 25 mg and 50 mg-Bupropion
- Dolutegravir 25 mg and 50 mg-Bupropion and naltrexone